Comparison of amlodipine with cilnidipine on antihypertensive efficacy and incidence of pedal edema in mild to moderate hypertensive individuals: A prospective study
- PMID: 25878978
- PMCID: PMC4397623
- DOI: 10.4103/2231-4040.154543
Comparison of amlodipine with cilnidipine on antihypertensive efficacy and incidence of pedal edema in mild to moderate hypertensive individuals: A prospective study
Abstract
To compare amlodipine with cilnidipine on antihypertensive efficacy and incidence of pedal edema in hypertensive individuals. This was a three months prospective, observational study done at the tertiary care center of Karnataka, India. A total number of 60 (n = 60) newly diagnosed hypertensives (≥140/90) of either gender, attending outpatient department of medicine, were included in the study. Out of 60 patients, 30 patients who have been prescribed tablet amlodipine 5-10 mg/day and the other 30 who have been prescribed tablet cilnidipine 10-20 mg/day orally by the consulting physician, depending upon the severity of hypertension were followed every fortnight, screened for the presence of pedal edema and blood pressure control over a period of 3 months. Antihypertensive efficacy between two groups was compared by unpaired t-test and incidence of pedal edema was compared by Fisher's exact test. Of 30 patients in the amlodipine group, 19 patients presented with pedal edema (63.3%) and 2 patients (6.66%) in cilnidipine group presented with pedal edema during the study period. There was a significant difference in the incidence of pedal edema between amlodipine and cilnidipine group (P < 0.05), but no significant difference was found in the antihypertensive efficacy of amlodipine and cilnidipine (P > 0.05). Both amlodipine and cilnidipine have shown equal efficacy in reducing blood pressure in hypertensive individuals. But cilnidipine being N-type and L-type calcium channel blocker, associated with lower incidence of pedal edema compared to only L-type channel blocked by amlodipine.
Keywords: Blood pressure; N-type and T-type calcium channels; calcium channel blockers.
Conflict of interest statement
Figures
Similar articles
-
A Retrospective, Observational, EMR-Based Real-World Evidence Study to Assess the Incidence of Pedal Edema in Essential Hypertensive Patients on Amlodipine or Cilnidipine.Int J Hypertens. 2022 Feb 23;2022:6868143. doi: 10.1155/2022/6868143. eCollection 2022. Int J Hypertens. 2022. PMID: 35251710 Free PMC article.
-
Cilnidipine for Amlodipine Induced Pedal Edema and its Anti-hypertensive Effect in a Tertiary Care Teaching Hospital of Western Nepal.J Nepal Health Res Counc. 2021 Dec 15;19(3):618-621. doi: 10.33314/jnhrc.v19i3.3583. J Nepal Health Res Counc. 2021. PMID: 35140441
-
A Randomized Open-Label Parallel-Group Study Comparing the Efficacy and Safety of Cilnidipine and Amlodipine in Hypertensive Adults.J Assoc Physicians India. 2022 Dec;69(12):11-12. J Assoc Physicians India. 2022. PMID: 35057591 Clinical Trial.
-
The Promise of Cilnidipine in Hypertension with Comorbidities: National Consensus Statement: National Consensus Group Comprises Cardiologists, Nephrologists, and Diabetologists from India in a National Meet at New Delhi held on 22nd May 2022.J Assoc Physicians India. 2024 Jan;72(1):88-95. doi: 10.59556/japi.71.0400. J Assoc Physicians India. 2024. PMID: 38736080
-
Blood Pressure Reducing Potential and Renoprotective Action of Cilnidipine Among Hypertensive Patients Suffering From Chronic Kidney Disease: A Meta-Analysis.Cureus. 2023 Apr 18;15(4):e37774. doi: 10.7759/cureus.37774. eCollection 2023 Apr. Cureus. 2023. PMID: 37213948 Free PMC article. Review.
Cited by
-
Effects of triptolide on pharmacokinetics of amlodipine in rats by using LC-MS/MS.Pharm Biol. 2018 Dec;56(1):132-137. doi: 10.1080/13880209.2018.1430835. Pharm Biol. 2018. PMID: 29385884 Free PMC article.
-
Retrospective Electronic Medical Records Study to Understand the Usage Patterns and Patient Profiles of Those Prescribed Amlodipine and Its Combinations.Cureus. 2025 Jul 29;17(7):e88954. doi: 10.7759/cureus.88954. eCollection 2025 Jul. Cureus. 2025. PMID: 40896048 Free PMC article.
-
Effect of Ginkgo Leaf Tablets on the Pharmacokinetics of Amlodipine in Rats.Eur J Drug Metab Pharmacokinet. 2016 Dec;41(6):825-833. doi: 10.1007/s13318-015-0312-3. Eur J Drug Metab Pharmacokinet. 2016. PMID: 26650374
-
RSSDI Guidelines for the management of hypertension in patients with diabetes mellitus.Int J Diabetes Dev Ctries. 2022 Oct;42(4):576-605. doi: 10.1007/s13410-022-01143-7. Epub 2022 Dec 15. Int J Diabetes Dev Ctries. 2022. PMID: 36536953 Free PMC article. Review.
-
Effects of Danshen tablets on pharmacokinetics of amlodipine in rats.Pharm Biol. 2019 Dec;57(1):306-309. doi: 10.1080/13880209.2019.1604768. Pharm Biol. 2019. PMID: 31060428 Free PMC article.
References
-
- Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jr, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA. 2003;289:2560–72. - PubMed
-
- Ecological analysis of the association between mortality and major risk factors of cardiovascular disease. The World Health Organization MONICA Project. Int J Epidemiol. 1994;23:505–16. - PubMed
-
- Wolf-Maier K, Cooper RS, Banegas JR, Giampaoli S, Hense HW, Joffres M, et al. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA. 2003;289:2363–9. - PubMed
-
- Vasan RS, Beiser A, Seshadri S, Larson MG, Kannel WB, D'Agostino RB, et al. Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study. JAMA. 2002;287:1003–10. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources